Background Image
Table of Contents Table of Contents
Previous Page  22 / 74 Next Page
Information
Show Menu
Previous Page 22 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 5, September/October 2018

284

AFRICA

Exclusion criteria were hypertension (blood pressure

140/90 mmHg or use of antihypertensive drugs), age above

65 years, macroalbuminuria, serum creatinine of

1.5 mg/

dl, chest deformity or long-standing chest disease evidenced

on chest X-ray, sickle cell disease, urinary tract infection,

pregnancy, cardiac conditions such as arrhythmia, heart failure,

valvular heart disease, pericardial disease, congenital heart

disease, and ischaemic heart disease as evidenced by clinical,

electrocardiographic and echocardiographic features.

Age, gender and duration of diabetes were recorded for

each subject. Weight was determined in kilograms (kg) using

a weighing scale, height using a stadiometer, and waist and hip

circumferences (WC and HC) were measured in centimetres (cm)

using a tape measure. Body mass index (BMI), body surface area

(BSA) and waist:hip ratio (WHR) were calculated.

Blood pressure was measured using an Accosson mercury

sphygmomanometer with appropriate sized cuff at the brachial

artery, Korotkoff phase 1 was used for systolic (SBP) and phase

5 for diastolic blood pressure (DBP) after at least 15 minutes

of rest in a sitting position. Pulse rate (PR) was measured at

the radial artery. The mean of three consecutive measurements,

taken at five-minute intervals, was recorded. An overnight

fasting venous blood sample was collected for measurement of

levels of plasma glucose, creatinine and urea, and lipid profile

using standard protocols.

A two-step microalbuminuria screening process was

conducted. Combur 10 test strip (Roche Diagnostics, Mannheim,

Germany), a visual colorimetric semi-quantitative urine test

strip, was used to test for protein, blood, nitrite and leucocyte

levels. If all were absent then detection of microalbuminuria was

performed on the same urine sample.

Microalbuminuria was determined using Micral test strips, an

optically read semi-quantitative immunoassay method (Roche

Diagnostics, Australia) with a sensitivity and specificity of 80

and 88%, respectively.

11

There are four colour blocks on the

test strip corresponding to negative (or 0), 20, 50 and 100 mg/l

of albumin. The test was done on two occasions; the first was

random urine samples (RUS) and the second was first morning

void (FMV) urine samples of the subjects.

Microalbuminuria was considered to be present when the

two urine samples produced a reaction colour corresponding

to 20 mg/l or more. The result from the FMV urine sample was

recorded as the MCA status of the subject. It has been suggested

that MCA detected in the FMV urine sample corresponds

better with 24-hour urinary albumin excretion (UAE) than

microalbuminuriameasured in a RUS, because it is less influenced

by physical exercise and diet.

12

Echocardiographic examination was performed with the

patient in the left lateral decubitus position using a Hewlett-

Packard Sonos 4500 echocardiography machine with a 3.5-MHz

transducer. Measurements were taken under two-dimensional

guided M-mode, as recommended by the American Society of

Echocardiography (ASE).

13

Endocardial fractional shortening (FS) was calculated

automatically by the echocardiography machine using the

formula:

14

FS

=

​ 

LVIDd – LVIDs

_____________

LVIDd 

×

100

where LVIDd is left ventricular internal dimension in diastole

and and LVIDs is left ventricular internal dimension in systole.

Left ventricular end-diastolic and end-systolic volumes

(LVEDV and LVESV) were calculated automatically by

the echocardiography machine from M-mode-derived LV

dimensions, using Teicholz’s formula:

LVEDV or LVESV

=

​ 

7.0

×

LVID

3

__________

2.4

+

LVID

Ejection fraction (EF) was calculated using the formula:

EF

=

​ 

EDV – ESV

__________ 

EDV 

×

100

The LV systolic function was considered normal if the EF

was greater than 50% and/or FS was greater than 25%.

14

The LV

diastolic function was assessed using Doppler modalities. Early

(E) and atrial (A) velocities as well as deceleration time (DT)

were measured using pulsed-wave Doppler by placing the sample

volume at the tips of the mitral leaflets in apical four-chamber

view. Isovolumic relaxation time (IVRT) was measured as the

time interval from the end of LV outflow and start of LV inflow,

as indicated by simultaneous registration of outflow and inflow

signals by high-frequency pulsed-wave Doppler.

Pulmonary venous flow (PVF), systolic (S), diastolic (D) and

atrial reversal (Ar) velocities were obtained by placing a pulsed-

wave Doppler sample volume 1–2 cm into the pulmonary vein,

proximal to its insertion into the left atrium. E/A and S/D were

calculated.

Diastolic function (DF) was categorised into grades according

to its progression to diastolic dysfunction (DD):

normal DF: E/A between 1 and 2, IVRT 60–100 ms and DT

160–240 ms

grade 1 DD: E/A

<

1, IVRT

>

100 ms, DT

>

240 ms

grade 2 DD: E/A 1– 2, IVRT 60–100 ms, DT 150–220 ms,

PVFS/D

<

1

grade 3 DD: E/A

>

2, IVRT

<

60 ms, DT

<

160 ms.

15

where DT is deceleration time and PVFS is pulmonary venous

flow S velocity.

Pulmonary artery systolic pressure (PASP) was estimated from

peak tricuspid regurgitant flow using continuous-wave Doppler.

Tissue Doppler echocardiography was not used because, at the

time the study was conducted, the echo machine used did not

have the facility.

Statistical analysis

Data obtained were analysed using STATA 10. Continous

variables are expressed as mean (

±

standard deviation) and

categorical variables as percentages. Categorical variables were

analysed using the chi-squared test. Student’s

t

-test and analysis

of variance (ANOVA) were used to analyse continuous variables.

Correlates of LV function were determined using Pearson’s rank

correlation and predictors were assessed using logistic regressions.

A

p

-value

0.05 was considered statistically significant.

Results

One hundred and ninety-three participants comprising 63

T2DM patients with normoalbuminuria, 71 T2DM with

microalbuminuria and 59 controls were studied. The mean age

for all participants was 50 years and the three groups were age

and gender matched. Table 1 shows the clinical characteristics

of the three study groups. The duration since diagnosis of DM

was significantly longer in the microalbuminuric than in the